title: The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.
abstract: The proproliferative transcription factor KLF5 plays an important role in promoting cell proliferation and tumorigenesis. KLF5 is a short-lived protein that can be rapidly degraded through the ubiquitin-proteasome pathway in cancer cells. However, the mechanisms regulating protein stability remain poorly understood. In this study, the tumor suppressor Fbw7, a component of the SCF complex (SCF(Fbw7)) E3 ubiquitin ligase, specifically promoted the degradation and ubiquitination of KLF5 but had little effect on the stability of KLF4. Fbw7 interacted with KLF5 in a CDC4 phosphodegron (CPD)-dependent manner. Three CPDs were found in the KLF5 protein. Simultaneous mutation of these CPDs significantly abolished Fbw7-mediated ubiquitination and degradation. Furthermore, Fbw7 deficiency dramatically delayed KLF5 turnover and led to the accumulation of KLF5 protein in cancer cells. Glycogen synthase kinase-3beta could phosphorylate and promote Fbw7-mediated KLF5 degradation. More importantly, Fbw7 negatively regulated the biological activity of KLF5 in gene regulation and cell proliferation. Taken together, these data indicate that Fbw7 is a key negative regulator controlling KLF5-mediated cell proliferation and suggest an additional mechanism linking the loss of Fbw7 function to tumorigenesis.
authors.affiliation: Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.
authors.forename: Ning
authors.initials: N
authors.lastname: Liu
authors.forename: Hui
authors.initials: H
authors.lastname: Li
authors.forename: Shuangxi
authors.initials: S
authors.lastname: Li
authors.forename: Mingyue
authors.initials: M
authors.lastname: Shen
authors.forename: Ning
authors.initials: N
authors.lastname: Xiao
authors.forename: Yunfei
authors.initials: Y
authors.lastname: Chen
authors.forename: Yan
authors.initials: Y
authors.lastname: Wang
authors.forename: Weichao
authors.initials: W
authors.lastname: Wang
authors.forename: Rui
authors.initials: R
authors.lastname: Wang
authors.forename: Qian
authors.initials: Q
authors.lastname: Wang
authors.forename: Jianhua
authors.initials: J
authors.lastname: Sun
authors.forename: Ping
authors.initials: P
authors.lastname: Wang
mesh_terms: D020816:Amino Acid Motifs; D018797:Cell Cycle Proteins / Q000378:metabolism / Q000502:physiology*; D002460:Cell Line; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D003593:Cytoplasm / Q000378:metabolism; D044783:F-Box Proteins / Q000378:metabolism / Q000502:physiology*; D000073979:F-Box-WD Repeat-Containing Protein 7; D005434:Flow Cytometry / Q000379:methods; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006367:HeLa Cells; D006801:Humans; D000090062:Kruppel-Like Factor 4; D051741:Kruppel-Like Transcription Factors / Q000378:metabolism / Q000502:physiology*; D009154:Mutation; D010766:Phosphorylation; D025801:Ubiquitin / Q000737:chemistry*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism / Q000502:physiology*
chemical_list: D018797:Cell Cycle Proteins; D044783:F-Box Proteins; D000073979:F-Box-WD Repeat-Containing Protein 7; C513273:FBXW7 protein, human; C000715467:KLF4 protein, human; C492214:KLF5 protein, human; D000090062:Kruppel-Like Factor 4; D051741:Kruppel-Like Transcription Factors; D025801:Ubiquitin; D044767:Ubiquitin-Protein Ligases; C000605506:GSK3B protein, human; D000071679:Glycogen Synthase Kinase 3 beta; D038362:Glycogen Synthase Kinase 3
references.citation: J Biol Chem. 2005 Dec 16;280(50):41553-61
references.pmid: 16223724
references.citation: J Biol Chem. 2001 Sep 14;276(37):34355-8
references.pmid: 11443140
references.citation: Nat Med. 2008 Jun;14(6):656-66
references.pmid: 18500350
references.citation: Mol Cell Biol. 2009 Dec;29(23):6192-205
references.pmid: 19797085
references.citation: Int J Cancer. 2007 Jul 1;121(1):80-87
references.pmid: 17330240
references.citation: Clin Cancer Res. 2006 Apr 15;12(8):2442-8
references.pmid: 16638850
references.citation: Oncogene. 2009 Jun 25;28(25):2393-405
references.pmid: 19421138
references.citation: J Biol Chem. 2009 Apr 3;284(14):9549-57
references.pmid: 19189969
references.citation: Science. 2008 Sep 12;321(5895):1499-502
references.pmid: 18787170
references.citation: Curr Biol. 2004 Oct 26;14(20):1852-7
references.pmid: 15498494
references.citation: Histol Histopathol. 2009 Oct;24(10):1343-55
references.pmid: 19688699
references.citation: Mol Cancer Ther. 2009 Mar;8(3):563-70
references.pmid: 19240162
references.citation: Nat Cell Biol. 2008 Mar;10(3):353-60
references.pmid: 18264089
references.citation: Science. 2008 Nov 7;322(5903):923-9
references.pmid: 18988848
references.citation: J Biol Chem. 2008 Nov 14;283(46):31991-2002
references.pmid: 18782761
references.citation: Science. 2004 Feb 27;303(5662):1374-8
references.pmid: 14739463
references.citation: J Exp Med. 2007 Aug 6;204(8):1813-24
references.pmid: 17646409
references.citation: Genes Dev. 2008 Jan 15;22(2):252-64
references.pmid: 18198341
references.citation: Nucleic Acids Res. 2003 Apr 15;31(8):2196-208
references.pmid: 12682370
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9085-90
references.pmid: 15150404
references.citation: Cell Div. 2007 Feb 13;2:7
references.pmid: 17298674
references.citation: J Biol Chem. 2003 Feb 21;278(8):6363-70
references.pmid: 12488444
references.citation: Mol Cell Biol. 2001 Jan;21(2):562-74
references.pmid: 11134343
references.citation: Oncogene. 2007 Apr 5;26(16):2386-94
references.pmid: 17016436
references.citation: J Biol Chem. 2004 Mar 26;279(13):12093-101
references.pmid: 14726538
references.citation: Gastroenterology. 2008 Apr;134(4):1007-16
references.pmid: 18395082
references.citation: Trends Biochem Sci. 2010 Mar;35(3):161-8
references.pmid: 19884009
references.citation: Prostate. 2003 May 1;55(2):81-8
references.pmid: 12661032
references.citation: Cancer Cell. 2008 Jan;13(1):36-47
references.pmid: 18167338
references.citation: EMBO J. 2004 May 19;23(10):2116-25
references.pmid: 15103331
references.citation: J Cell Physiol. 2001 Aug;188(2):143-60
references.pmid: 11424081
references.citation: Cancer Res. 2005 Nov 15;65(22):10394-400
references.pmid: 16288030
references.citation: Bioessays. 2007 Jun;29(6):549-57
references.pmid: 17508399
references.citation: J Biol Chem. 2006 May 26;281(21):14711-8
references.pmid: 16595680
references.citation: J Biol Chem. 2007 May 25;282(21):15541-9
references.pmid: 17430902
references.citation: Nature. 2004 Mar 4;428(6978):77-81
references.pmid: 14999283
references.citation: Cancer Res. 2007 Oct 1;67(19):9006-12
references.pmid: 17909001
references.citation: Cell. 2003 Jan 24;112(2):243-56
references.pmid: 12553912
references.citation: Int J Cancer. 2009 Jun 15;124(12):2829-36
references.pmid: 19267401
references.citation: Nature. 2004 Dec 9;432(7018):775-9
references.pmid: 15592418
references.citation: Nat Rev Cancer. 2008 Feb;8(2):83-93
references.pmid: 18094723
references.citation: Oncogene. 2005 May 5;24(20):3319-27
references.pmid: 15735697
references.citation: Oncogene. 2009 Oct 22;28(42):3702-13
references.pmid: 19668233
references.citation: Cancer Res. 2009 May 15;69(10):4125-33
references.pmid: 19435907
references.citation: J Biol Chem. 2004 Mar 26;279(13):12300-11
references.pmid: 14711826
references.citation: Cell Mol Life Sci. 2009 Aug;66(16):2691-706
references.pmid: 19448973
references.citation: J Biol Chem. 2001 Mar 9;276(10):6897-900
references.pmid: 11152667
references.citation: Mol Cell. 2007 Apr 13;26(1):131-43
references.pmid: 17434132
references.citation: J Cell Biol. 2008 Jun 16;181(6):913-20
references.pmid: 18559665
references.citation: Science. 2001 Oct 5;294(5540):173-7
references.pmid: 11533444
references.citation: Int J Cancer. 2006 Mar 15;118(6):1346-55
references.pmid: 16184550
references.citation: Cell Cycle. 2004 Jun;3(6):693-4
references.pmid: 15118416
references.citation: Cell Metab. 2005 Jun;1(6):379-91
references.pmid: 16054087